Cronos Group Inc (CRON) Stock Surges as US Marijuana Rescheduling Buzz Returns — Latest News, Forecasts, and Key Catalysts (Dec. 12, 2025)
Cronos Group shares jumped as much as 19% in premarket trading Dec. 12 after reports that President Trump may seek to reclassify marijuana as a Schedule III drug. Reuters and other outlets cited broad gains across cannabis stocks on the news. Cronos recently announced a strategic acquisition in the Netherlands, aiming for top market share in Europe's largest adult-use market. No final decisions on U.S. policy have been confirmed.
